Detalhe da pesquisa
1.
Efficacy and safety of respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over 2 RSV seasons.
Clin Infect Dis
; 2024 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38253338
2.
Performance Assessment of a Rapid Molecular Respiratory Syncytial Virus Point-of-Care Test: A Prospective Community Study in Older Adults.
J Infect Dis
; 226(Suppl 1): S63-S70, 2022 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35134954
3.
Clinical and Viral Factors Associated With Disease Severity and Subsequent Wheezing in Infants With Respiratory Syncytial Virus Infection.
J Infect Dis
; 226(Suppl 1): S45-S54, 2022 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35902389
4.
Incidence of Respiratory Syncytial Virus Lower Respiratory Tract Infections During the First 2 Years of Life: A Prospective Study Across Diverse Global Settings.
J Infect Dis
; 226(3): 374-385, 2022 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35668702
5.
Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort study.
Eur Respir J
; 57(4)2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33060153
6.
Respiratory syncytial virus acute respiratory infections in ≥ 65-year-old adults in long-term care facilities in the Czech Republic.
Cent Eur J Public Health
; 29(3): 167-176, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34623114
7.
Evaluation of Clinical Case Definitions for Respiratory Syncytial Virus Lower Respiratory Tract Infection in Young Children.
J Pediatric Infect Dis Soc
; 12(5): 273-281, 2023 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142551
8.
Leveraging Influenza Virus Surveillance From 2012 to 2015 to Characterize the Burden of Respiratory Syncytial Virus Disease in Canadian Adults ≥50 Years of Age Hospitalized With Acute Respiratory Illness.
Open Forum Infect Dis
; 10(7): ofad315, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37441353
9.
Gene expression of MAGE-A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non-small cell lung cancer patients.
Asia Pac J Clin Oncol
; 13(5): e212-e223, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27519286
10.
The prevalence of expression of MAGE-A3 and PRAME tumor antigens in East and South East Asian non-small cell lung cancer patients.
Lung Cancer
; 101: 137-144, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27794402
11.
Development of a Quantitative Real-Time RT-PCR Assay for the Detection of MAGE-A3-Positive Tumors.
J Mol Diagn
; 17(4): 382-91, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25986000
12.
Rates of MAGE-A3 and PRAME expressing tumors in FFPE tissue specimens from bladder cancer patients: potential targets for antigen-specific cancer immunotherapeutics.
Int J Clin Exp Pathol
; 8(8): 9522-32, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26464715
13.
Predictive gene signature in MAGE-A3 antigen-specific cancer immunotherapy.
J Clin Oncol
; 31(19): 2388-95, 2013 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23715562